Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
T-Regulatory Cell Infusion in Kidney Transplantation (The ONE Study)
NCT02091232Phase 1Completed
- Sponsor
- Massachusetts General Hospital
- Start
- May 2014
- Primary completion
- Mar 2016
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of t regulatory cell infusion in kidney failure (ESRD), sponsored by Massachusetts General Hospital. Primary endpoint: Safety and Feasibility of T Regulatory Cell Infusion in Renal Transplantation at 2 weeks. Started May 2014; status: completed.
02
Drugs
t regulatory cell infusion
03
Conditions
kidney failure (ESRD)
Beyond the preview
Go deeper on NCT02091232.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02091232.